Article: In patients with a high 5 year risk of death, does simvastatin reduce mortality and vascular events?
| Title | In patients with a high 5 year risk of death, does simvastatin reduce mortality and vascular events? |
|---|---|
| Authors | Kumana, CR Cheung, BM Lauder, IJ |
| Keywords | Artery Occlusion Cancer Incidence Cardiovascular Disease Clinical Trial Death Diabetes Mellitus Diet Restriction Diet Supplementation Dose Response Drug Safety Drug Use Factorial Analysis Follow Up Heart Protection High Risk Patient Human Hypertension Ischemic Heart Disease Malignant Neoplastic Disease Mortality Patient Compliance Patient Selection Prescription Quality Of Life Risk Assessment Risk Reduction Short Survey Stroke Treatment Outcome United Kingdom Vascular Disease |
| Issue Date | 2003 |
| Publisher | B M J Publishing Group. The Journal's web site is located at http://www.evidence-basedmedicine.com |
| Citation | Evidence-Based Medicine, 2003, v. 8 n. 1, p. 10 [How to Cite?] DOI: http://dx.doi.org/10.1136/ebm.8.1.10 |
| ISSN | 1356-5524 2011 SCImago Journal Rankings: 0.075 |
| DOI | http://dx.doi.org/10.1136/ebm.8.1.10 |
| References | References in Scopus |
| dc.contributor.author | Kumana, CR |
|---|---|
| dc.contributor.author | Cheung, BM |
| dc.contributor.author | Lauder, IJ |
| dc.date.accessioned | 2010-09-17T10:22:22Z |
| dc.date.available | 2010-09-17T10:22:22Z |
| dc.date.issued | 2003 |
| dc.description.nature | Link_to_subscribed_fulltext |
| dc.identifier.citation | Evidence-Based Medicine, 2003, v. 8 n. 1, p. 10 [How to Cite?] DOI: http://dx.doi.org/10.1136/ebm.8.1.10 |
| dc.identifier.doi | http://dx.doi.org/10.1136/ebm.8.1.10 |
| dc.identifier.issn | 1356-5524 2011 SCImago Journal Rankings: 0.075 |
| dc.identifier.issue | 1 |
| dc.identifier.scopus | eid_2-s2.0-80051953944 |
| dc.identifier.spage | 10 |
| dc.identifier.uri | http://hdl.handle.net/10722/91623 |
| dc.identifier.volume | 8 |
| dc.language | eng |
| dc.publisher | B M J Publishing Group. The Journal's web site is located at http://www.evidence-basedmedicine.com |
| dc.relation.ispartof | Evidence-Based Medicine |
| dc.relation.references | References in Scopus |
| dc.subject | Artery Occlusion |
| dc.subject | Cancer Incidence |
| dc.subject | Cardiovascular Disease |
| dc.subject | Clinical Trial |
| dc.subject | Death |
| dc.subject | Diabetes Mellitus |
| dc.subject | Diet Restriction |
| dc.subject | Diet Supplementation |
| dc.subject | Dose Response |
| dc.subject | Drug Safety |
| dc.subject | Drug Use |
| dc.subject | Factorial Analysis |
| dc.subject | Follow Up |
| dc.subject | Heart Protection |
| dc.subject | High Risk Patient |
| dc.subject | Human |
| dc.subject | Hypertension |
| dc.subject | Ischemic Heart Disease |
| dc.subject | Malignant Neoplastic Disease |
| dc.subject | Mortality |
| dc.subject | Patient Compliance |
| dc.subject | Patient Selection |
| dc.subject | Prescription |
| dc.subject | Quality Of Life |
| dc.subject | Risk Assessment |
| dc.subject | Risk Reduction |
| dc.subject | Short Survey |
| dc.subject | Stroke |
| dc.subject | Treatment Outcome |
| dc.subject | United Kingdom |
| dc.subject | Vascular Disease |
| dc.title | In patients with a high 5 year risk of death, does simvastatin reduce mortality and vascular events? |
| dc.type | Article |
Author Affiliations
- Clinical Trial Service Unit

